Hims & Hers Health, Inc.HIMSNYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank48
3Y CAGR-39.0%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-39.0%/yr
Quarterly compound
Percentile
P48
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 0.95% |
| Q3 2025 | 7.21% |
| Q2 2025 | 26.52% |
| Q1 2025 | 25.96% |
| Q4 2024 | 12.60% |
| Q3 2024 | 13.07% |
| Q2 2024 | 21.73% |
| Q1 2024 | 14.32% |
| Q4 2023 | 9.25% |
| Q3 2023 | 3.95% |
| Q2 2023 | 9.83% |
| Q1 2023 | 29.32% |
| Q4 2022 | 4.19% |
| Q3 2022 | 16.27% |
| Q2 2022 | 12.70% |
| Q1 2022 | 0.00% |
| Q4 2021 | -100.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |